Recent Updates
Recently added Catalysts
BLTE Neutral Sentiment

Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results

Monday, August 4, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Belite Bio, Inc., a clinical-stage drug development company, has announced a webcast to discuss its financial results and give a business update for the second quarter of 2025. The event is scheduled for August 11, 2025, at 4:30 p.m. Eastern Time. Participants can access the webcast through a provided link or the company's Investor Relations website. A replay will be available for 90 days following the event.
Price reaction · baseline $65.72 (2025-08-01 close) · 2 other BLTE headline(s) in the window, move may be shared
day 0 close
+6.2%
day 1
+0.9%
day 3 · peak
+6.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Belite Bio is actively engaging with investors through a scheduled webcast.
  • The webcast will provide financial results and a business update, showing transparency.
  • Focus on developing novel therapeutics for degenerative retinal diseases indicates innovation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
6.1%
average across 7 past catalysts
Lead asset
Tinlarebant
Phase 3 · Geographic Atrophy

Full Press Release Details

SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, August 11, 2025, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update for the second quarter ended June 30, 2025.
Date: Monday, August 11, 2025
Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
Webcast Link: https://events.q4inc.com/attendee/127464226
Webcast Link Instructions
You can join the live webcast by visiting the link above or the “Presentations & Events” section of the Company’s Investor Relations website at https://investors.belitebio.com/presentations-events/events. A replay will be available for approximately 90 days after the event.
Media and Investor Relations Contact:

Frequently Asked Questions

When will Belite Bio host its webcast?

Belite Bio's webcast is on August 11, 2025, at 4:30 p.m. ET.

What will be discussed during the webcast?

The webcast will cover financial results and a business update for Q2 2025.

How can I access the webcast?

You can join via the provided link or the Company's Investor Relations website.

Is there a replay available for the webcast?

Yes, a replay will be accessible for about 90 days post-event.

What is the main focus of Belite Bio?

Belite Bio is focused on developing therapies for degenerative retinal diseases.

ShareAdd on Google
Tags: BLTE Viatris Investor Conferences Healthcare financial results business update webcast retinal diseases
Last updated: Aug 4, 2025

Biotech snapshot

Lead asset
TinlarebantPhase 3
Geographic Atrophy →

Catalyst track record

+33%
best trade around BLTE's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for BLTE.

See every catalyst's timing & PoA →